Ethinylestradiol/Levonorgestrel Teva

Ethinylestradiol/Levonorgestrel Teva is a prescription combined oral contraceptive that contains the synthetic estrogen ethinylestradiol and the progestogen levonorgestrel. It is marketed in the European Union and supplied as an oral tablet, though specific strength information is not disclosed here. The product works by preventing ovulation and creating cervical and endometrial conditions unfavorable for fertilisation. It is intended for use by women seeking birth control and is classified under hormonal contraceptives.

Ethinylestradiol/Levonorgestrel Teva is indicated for hormonal contraception in women of reproductive age.

- Prevention of pregnancy when taken as directed in a cyclic regimen. - Regulation of menstrual cycles and reduction of dysmenorrhea. - Management of acne associated with androgen excess. - Decrease in the risk of ovarian cyst formation. - Potential benefit in reducing the incidence of endometrial hyperplasia.

Side effects of Ethinylestradiol/Levonorgestrel Teva vary in frequency and severity; most are mild and transient, while rare events may require medical attention.

Common: - Nausea or mild gastrointestinal upset. - Breast tenderness. - Spotting or breakthrough bleeding. - Mood changes such as irritability.

Serious: - Deep vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Severe allergic reaction with rash or swelling.

Before prescribing Ethinylestradiol/Levonorgestrel Teva, clinicians should evaluate individual risk factors and counsel patients on appropriate use.

- Not for use during pregnancy; contraindicated in women with known or suspected pregnancy (Category X). - Avoid in patients with a history of thromboembolic disorders, stroke, or myocardial infarction. - Use with caution in smokers aged 35 years or older. - Screen for hypertension, diabetes, or liver disease before initiation. - Discuss potential interactions with other hormonal medications. - Advise against use in women with estrogen‑dependent tumors. - Ensure regular follow‑up to monitor blood pressure and menstrual changes.

Ethinylestradiol/Levonorgestrel Teva can interact with several medicines, affecting efficacy or safety.

Avoid: - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) that reduce contraceptive effectiveness. - Rifampin or other potent CYP3A4 inducers. - Certain antiretroviral agents (e.g., efavirenz) that lower hormone levels.

Use with caution: - Antifungal azoles (e.g., ketoconazole) that may increase hormone concentrations. - St. John’s wort, a mild CYP3A4 inducer. - Selective serotonin reuptake inhibitors (SSRIs) that can affect bleeding patterns.